Estadístiques de Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade
Visites totals
| views | |
|---|---|
| Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade | 43 |
Visites totals per mes
| views | |
|---|---|
| April 2025 | 0 |
| May 2025 | 1 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 1 |
| October 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| gomez-jic-anti.pdf | 110 |
| gomez-jic-anti.pdf(legacy) | 33 |
Vistes principals per país
| views | |
|---|---|
| United States | 37 |
| Australia | 2 |
| Spain | 1 |
| Malaysia | 1 |
| Sweden | 1 |
| Venezuela | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Boardman | 11 |
| Ann Arbor | 7 |
| Mountain View | 6 |
| San Ramon | 5 |
| Ashburn | 2 |
| Fairfield | 2 |
| Menlo Park | 2 |
| Caracas | 1 |
| Córdoba | 1 |
| Dickson | 1 |
| Shah Alam | 1 |
| Timboon | 1 |